Delivery Order SPE2DB22D2005-SPE2DB25FJRR2
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,292.07 on August 27, 2025, for the supply of Progesterone 100 mg capsules (100-count units). This contract represents a non-competitive, firm fixed-price delivery order with performance completion scheduled for August 28, 2025, and will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Progesterone 100 mg capsules (100-count units) with a ceiling value of $1,013.23. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. The contract is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Progesterone 100 mg capsules (100-count units) under a firm fixed-price contract valued at $2,517.98. The order is not set-aside and represents a competitively awarded delivery against AmerisourceBergen's larger federal pharmaceutical supply contracts. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Progesterone 100 mg capsules in quantities of 30 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $7,001.13 and is scheduled for completion by July 30, 2025. The contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply arrangements with the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract ceiling value of $7,427.51. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, represents a competitively awarded, non-set-aside contract executed through AmerisourceBergen's existing pharmaceutical supply vehicle with the federal government. The product will be delivered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count units) on August 20, 2025, with a ceiling value of $4,312.01 and a firm fixed price structure. This non-set-aside delivery order is expected to be completed by August 21, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement to support federal medical supply needs, leveraging...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Progesterone 200 mg capsules in quantities of 100 units. This firm fixed-price delivery order, valued at $10,748.99, is scheduled for completion by September 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made on a non-set-aside basis through competitive procurement procedures, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Progesterone 100 mg capsules in quantities of 30 units. This competitively awarded, non-set-aside contract is valued at $1,796.47 with a firm fixed price structure and an ultimate completion date of August 26, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Progesterone 200 mg capsules (100 count) with a ceiling value of $4,508.52. This is a firm fixed price delivery order issued under a non-competitive, non-set-aside contract vehicle, with an ultimate completion date of August 19, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains significant...
- The Defense Logistics Agency awarded a $1,152.00 delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count) on July 30, 2025, with a completion date of July 31, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJRR2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Progesterone 100 mg capsules (100-count units) with a ceiling value of $30,912.13. This firm fixed-price delivery order, which is expected to be completed by August 15, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting the contractor's capability to compete in the federal pharmaceutical procurement marketplace. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies a broad range of medications and medical commodities to support military healthcare programs and federal medical supply chains. The company's federal contract portfolio demonstrates significant experience delivering both brand-name and generic pharmaceuticals across multiple therapeutic domains to military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.9k | 8/14/25 |